Bill Text: PA HB1123 | 2023-2024 | Regular Session | Introduced

Bill Title: Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Spectrum: Partisan Bill (Republican 8-0)

Status: (Introduced) 2023-05-05 - Referred to HEALTH [HB1123 Detail]

Download: Pennsylvania-2023-HB1123-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

PA SB82 In short title and definitions, further providing for
PA HB2137 Establishing the Maternal and Newborn Supply Kit Program; and imposing...
NH HB243 Requiring the tabulation of votes in elections to be done in public.
RI H7477 JOINT RESOLUTION CONFERRING LIMITED PURPOSE RECOGNITION TO THE NATIVE AMERICAN...
US SB146 Cap Insulin Prices Act
IL HB5238 MOBILE HOME-WEATHER RADIO
NJ S3503 Provides corporation business and gross income tax credit for certain Pre-Broadway...
CA AB3108 Business: mortgage fraud.
MI HB5503 Appropriations: school aid; fiscal year 2024-2025 appropriations for K-12...
NH HB1215 Relative to development approvals and appeals, and allowing the town of...
feedback